Back to Market Feed

Product Information

DEXTROAMP-AMPHETAM 12.5 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3592 per EA under NDC 31722015801. Its NADAC has been published 247 times since Jan 12, 2022.

FDA first approved this application on Apr 22, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1

NDC

31722015801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213709

FDA Approved

4/22/2021

TE Code

AB

On Market Since

5/10/2021

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has been published 247 times since Jan 12, 2022, and over the history we have for it it has declined 34.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3592 per EA
All-time high$0.6985 (Sep 14, 2022)
All-time low$0.2862 (Nov 20, 2024)
52-week high$0.3621
52-week low$0.3065
Median price$0.4472
Average price$0.4667
Largest weekly change+70.2% (Dec 21, 2022)
Weeks tracked247
Tracking sinceJan 12, 2022

Price History

1W

0.0%

1M

+4.3%

3M

+8.8%

6M

+13.7%

1Y

-0.8%

3Y

-32.5%

5Y

N/A

All

-34.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BACK-BODY PAIN 500-32.5 MG CPLT
Generic
70000012702•Cardinal Health
$0.0422
per EA
EXTRA PAIN RELIEF CAPLET
Generic
49483037000•Time-Cap Labs Inc.
$0.0621
per EA
TENSION HEADACHE CAPLET
Generic
70000015901•Cardinal Health
$0.0622
per EA
TENSION HEADACHE CAPLET
Generic
70000015902•Cardinal Health
$0.0622
per EA
QC HEADACHE RELIEF TABLET
Generic
63868048501•Chain Drug Marketing Association
$0.0629
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037462•L. Perrigo Company
$0.0648
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037478•L. Perrigo Company
$0.0648
per EA
PAIN RELIEVER PLS 250-250-65 MG
Generic
00536132601•Rugby Laboratories
$0.0648
per EA
MIGRAINE 250-250-65 MG CPLT
Generic
24385036571•AmerisourceBergen
$0.0648
per EA
MIGRAINE FORMULA CAPLET
Generic
24385036578•AmerisourceBergen
$0.0648
per EA

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Manufacturer

Camber Pharmaceuticals Inc. manufacturer profile

See the full portfolio, pricing trend, and other products from this labeler.

Drug market

dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate market comparison

Compare this molecule across participating manufacturers and inspect the broader market price spread.

Therapeutic class

Central Nervous System Stimulant class view

See how this drug behaves alongside other products in the same FDA pharmacologic class.

Trend hub

Latest market trends

Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.

Guide

Understanding NADAC pricing

Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAM 12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 12.5 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $0.3592 per EA (NDC 31722015801), effective Sep 30, 2026.

How has the price of DEXTROAMP-AMPHETAM 12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has declined 34.2%. It has been tracked across 247 weekly CMS publications since Jan 12, 2022.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 12.5 MG TAB?

Since Jan 12, 2022, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has ranged from a low of $0.2862 (Nov 20, 2024) to a high of $0.6985 (Sep 14, 2022), with a median of $0.4472 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAM 12.5 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAM 12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DEXTROAMP-AMPHETAM 12.5 MG TAB?

DEXTROAMP-AMPHETAM 12.5 MG TAB (NDC 31722015801) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.